Chapter/Section Purchase

1 Study Coverage
1.1 Oxaprozin Product Introduction
1.2 Market by Type
1.2.1 Global Oxaprozin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Oxaprozin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Chronic Infectious Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Neck Shoulder Wrist Syndrome
1.3.7 Periarthritis Of Shoulder
1.3.8 Gout
1.3.9 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
1.3.10 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaprozin Sales Estimates and Forecasts 2017-2028
2.2 Global Oxaprozin Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxaprozin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxaprozin Sales by Region
2.4.1 Global Oxaprozin Sales by Region (2017-2022)
2.4.2 Global Sales Oxaprozin by Region (2023-2028)
2.5 Global Oxaprozin Revenue by Region
2.5.1 Global Oxaprozin Revenue by Region (2017-2022)
2.5.2 Global Oxaprozin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxaprozin Sales by Manufacturers
3.1.1 Global Top Oxaprozin Manufacturers by Sales (2017-2022)
3.1.2 Global Oxaprozin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxaprozin in 2021
3.2 Global Oxaprozin Revenue by Manufacturers
3.2.1 Global Oxaprozin Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxaprozin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxaprozin Revenue in 2021
3.3 Global Oxaprozin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxaprozin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxaprozin Sales by Type
4.1.1 Global Oxaprozin Historical Sales by Type (2017-2022)
4.1.2 Global Oxaprozin Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxaprozin Sales Market Share by Type (2017-2028)
4.2 Global Oxaprozin Revenue by Type
4.2.1 Global Oxaprozin Historical Revenue by Type (2017-2022)
4.2.2 Global Oxaprozin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxaprozin Revenue Market Share by Type (2017-2028)
4.3 Global Oxaprozin Price by Type
4.3.1 Global Oxaprozin Price by Type (2017-2022)
4.3.2 Global Oxaprozin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxaprozin Sales by Application
5.1.1 Global Oxaprozin Historical Sales by Application (2017-2022)
5.1.2 Global Oxaprozin Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxaprozin Sales Market Share by Application (2017-2028)
5.2 Global Oxaprozin Revenue by Application
5.2.1 Global Oxaprozin Historical Revenue by Application (2017-2022)
5.2.2 Global Oxaprozin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxaprozin Revenue Market Share by Application (2017-2028)
5.3 Global Oxaprozin Price by Application
5.3.1 Global Oxaprozin Price by Application (2017-2022)
5.3.2 Global Oxaprozin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxaprozin Market Size by Type
6.1.1 North America Oxaprozin Sales by Type (2017-2028)
6.1.2 North America Oxaprozin Revenue by Type (2017-2028)
6.2 North America Oxaprozin Market Size by Application
6.2.1 North America Oxaprozin Sales by Application (2017-2028)
6.2.2 North America Oxaprozin Revenue by Application (2017-2028)
6.3 North America Oxaprozin Market Size by Country
6.3.1 North America Oxaprozin Sales by Country (2017-2028)
6.3.2 North America Oxaprozin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oxaprozin Market Size by Type
7.1.1 Europe Oxaprozin Sales by Type (2017-2028)
7.1.2 Europe Oxaprozin Revenue by Type (2017-2028)
7.2 Europe Oxaprozin Market Size by Application
7.2.1 Europe Oxaprozin Sales by Application (2017-2028)
7.2.2 Europe Oxaprozin Revenue by Application (2017-2028)
7.3 Europe Oxaprozin Market Size by Country
7.3.1 Europe Oxaprozin Sales by Country (2017-2028)
7.3.2 Europe Oxaprozin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxaprozin Market Size by Type
8.1.1 Asia Pacific Oxaprozin Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxaprozin Revenue by Type (2017-2028)
8.2 Asia Pacific Oxaprozin Market Size by Application
8.2.1 Asia Pacific Oxaprozin Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxaprozin Revenue by Application (2017-2028)
8.3 Asia Pacific Oxaprozin Market Size by Region
8.3.1 Asia Pacific Oxaprozin Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxaprozin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oxaprozin Market Size by Type
9.1.1 Latin America Oxaprozin Sales by Type (2017-2028)
9.1.2 Latin America Oxaprozin Revenue by Type (2017-2028)
9.2 Latin America Oxaprozin Market Size by Application
9.2.1 Latin America Oxaprozin Sales by Application (2017-2028)
9.2.2 Latin America Oxaprozin Revenue by Application (2017-2028)
9.3 Latin America Oxaprozin Market Size by Country
9.3.1 Latin America Oxaprozin Sales by Country (2017-2028)
9.3.2 Latin America Oxaprozin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxaprozin Market Size by Type
10.1.1 Middle East and Africa Oxaprozin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxaprozin Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxaprozin Market Size by Application
10.2.1 Middle East and Africa Oxaprozin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxaprozin Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxaprozin Market Size by Country
10.3.1 Middle East and Africa Oxaprozin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxaprozin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Overview
11.2.3 Helsinn Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Helsinn Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Helsinn Recent Developments
11.3 Taisho
11.3.1 Taisho Corporation Information
11.3.2 Taisho Overview
11.3.3 Taisho Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taisho Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taisho Recent Developments
11.4 Ildong
11.4.1 Ildong Corporation Information
11.4.2 Ildong Overview
11.4.3 Ildong Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ildong Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ildong Recent Developments
11.5 PD-Rx Pharmaceuticals
11.5.1 PD-Rx Pharmaceuticals Corporation Information
11.5.2 PD-Rx Pharmaceuticals Overview
11.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 PD-Rx Pharmaceuticals Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 PD-Rx Pharmaceuticals Recent Developments
11.6 Therapicon
11.6.1 Therapicon Corporation Information
11.6.2 Therapicon Overview
11.6.3 Therapicon Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Therapicon Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Therapicon Recent Developments
11.7 Neolpharma
11.7.1 Neolpharma Corporation Information
11.7.2 Neolpharma Overview
11.7.3 Neolpharma Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Neolpharma Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Neolpharma Recent Developments
11.8 Apotex Corporation
11.8.1 Apotex Corporation Corporation Information
11.8.2 Apotex Corporation Overview
11.8.3 Apotex Corporation Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Apotex Corporation Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apotex Corporation Recent Developments
11.9 Yichang Dongyangguang Changjiang Pharmaceutical
11.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
11.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Overview
11.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments
11.10 Hubei Baike Hengdi Pharmaceutical
11.10.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
11.10.2 Hubei Baike Hengdi Pharmaceutical Overview
11.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hubei Baike Hengdi Pharmaceutical Recent Developments
11.11 Fuan Pharmaceutical Group
11.11.1 Fuan Pharmaceutical Group Corporation Information
11.11.2 Fuan Pharmaceutical Group Overview
11.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Fuan Pharmaceutical Group Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fuan Pharmaceutical Group Recent Developments
11.12 Hubei Baike Hengdi Pharmaceutical
11.12.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
11.12.2 Hubei Baike Hengdi Pharmaceutical Overview
11.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hubei Baike Hengdi Pharmaceutical Recent Developments
11.31 Pfizer
11.31.1 Pfizer Corporation Information
11.31.2 Pfizer Overview
11.31.3 Pfizer Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.31.4 Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.31.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxaprozin Industry Chain Analysis
12.2 Oxaprozin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxaprozin Production Mode & Process
12.4 Oxaprozin Sales and Marketing
12.4.1 Oxaprozin Sales Channels
12.4.2 Oxaprozin Distributors
12.5 Oxaprozin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxaprozin Industry Trends
13.2 Oxaprozin Market Drivers
13.3 Oxaprozin Market Challenges
13.4 Oxaprozin Market Restraints
14 Key Findings in The Global Oxaprozin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer